Elimination of immune responses to viral vectors
US9861661B2 · kind B2 · utility
13Cited by
7References
15Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Apr 15, 2015 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Apr 15, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a viral vector antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or suppression of immune responses to viral vectors and in the manufacture of medicaments therefore.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.